Cell therapy is a rapidly evolving area of medicine that involves using living cells to treat or cure diseases. Companies focused on cell therapy are at the forefront of this exciting field, with many working on developing innovative treatments for various health conditions. Here is a brief summary of some of the top companies focused on cell therapy:
A2 Biotherapeutics is a biotech startup working on engineered T-cell therapies to treat cancer.
Abata Therapeutics is using regulatory T cells to develop treatments for autoimmune diseases.
Achilles Therapeutics is a biopharmaceutical company developing personalized T-cell therapies for cancer treatment.
Adaptate Biotherapeutics is developing antibody-based therapies that modulate gamma delta T-cells to treat cancer.
Adaptimmune is developing T-cell receptor therapies for cancer treatment.
Adaptive Biotechnologies is focused on T-cell and B-cell receptor analysis with Clonoseq.
Adicet Bio is working on off-the-shelf cellular therapies to treat cancer.
Affini-T Therapeutics is pioneering engineered TCR T-cell therapies with cutting-edge synthetic biology and gene editing.
Alaunos is a clinical-stage cellular immuno-oncology company dedicated to developing personalized cancer therapies.
Artielle ImmunoTherapeutics is developing recombinant T-cell receptor ligands.
Atara Biotherapeutics is focused on developing T-cell and molecularly-targeted therapies for cancer and viral diseases.
Autolus is at the forefront of developing CAR-T cell therapies for cancer treatment.
AVM Biotechnology is developing stem cell technologies, fully human biologics manufacturing cell lines, and regenerative therapies for various health conditions, including COVID-19.
Bellicum Pharmaceuticals is developing next-generation product candidates in cell and gene therapy, cancer therapeutics, and immunotherapy.
BioCopy is using microarray technology for immune profiling and lead screening for immunotherapy and vaccine development.
Biotecnol is focused on antibody technology for various therapeutic areas, including immunology and T-cell therapies.
Bluebird Bio is developing innovative therapies for cancer, sickle cell disease, and other health conditions using T-cells and other cell therapies.
CDR-Life is developing targeted cancer immunotherapies.
Cellectis is developing immunotherapies for blood and bone marrow cancers using T-cells.
Chimera Bioengineering is using RNA-based gene editing to solve challenges associated with CAR-T cell therapies.
Connect Biopharma is building a pipeline of internally designed T-cell therapies, antibodies, and small molecules.
Coya Therapeutics is developing a clinical-stage cell therapy platform for the treatment of neurological disorders.
CytomX Therapeutics is developing cancer immunotherapies, drug conjugates, and T-cell engaging Probody bispecifics for various health conditions.
Cytovia Therapeutics is focused on accelerating patient access to transformational cell therapies for cancer and COVID-19.
... to be continued
コメント